Table 4 Description of the cohort of patients hospitalised for a THA, TKA or TSA between 2010 and 2019
| Â | THA | TKA | TSA | |||
|---|---|---|---|---|---|---|
Centre I (n = 1,811) | Centre II (n = 2,302) | Centre I (n = 1,362) | Centre II (n = 1,268) | Centre I (n = 499) | Centre II (n = 345) | |
Sex ratio | 0.99 | 0.81 | 0.80 | 0.69 | 0.49 | 0.41 |
Age, mean (SD) | 66.8 (12.7) | 65.5 (13.9) | 69.1 (9.2) | 68.6 (10.1) | 70.1 (10.7) | 68.6 (11.4) |
Comorbidity, n(%) | ||||||
Cancer | 75 (4.1) | 27 (1.2) | 27 (1.9) | 6 (0.5) | 8 (1.6) | 1 (0.3) |
Cardiovascular disease | 127 (7.0) | 159 (6.9) | 85 (6.2) | 82 (6.5) | 24 (4.8) | 14 (4.0) |
Diabetes | 41 (2.3) | 88 (3.8) | 35 (2.6) | 68 (5.4) | 5 (1.0) | 16 (4.6) |
Hypertension | 111 (6.1) | 275 (11.9) | 85 (6.2) | 196 (15.4) | 31 (6.2) | 51 (14.8) |
Neurological disease | 42 (2.3) | 53 (2.3) | 25 (1.8) | 23 (1.8) | 14 (2.8) | 15 (4.3) |
Overweight | 91 (5.0) | 335 (14.5) | 104 (7.6) | 320 (25.2) | 26 (5.2) | 62 (17.9) |
Other comorbidity | 732 (40.4) | 1,235 (53.6) | 587 (43.1) | 799 (63.0) | 164 (32.9) | 173 (50.1) |